Skip to main content

Stream every public session from the 27th annual Global Conference right here on our website.

Will Digital Therapeutics Scale or Fail?

2023 Future of Health Summit

Will Digital Therapeutics Scale or Fail?

Tuesday, November 7, 2023
10:30 AM - 11:30 AM EST
Salamander Washington DC - Gallery A

In 2021, digital therapeutics benefited from record-breaking investment, up 134 percent from the previous year and topping out at nearly $9 billion. In 2023, however, the poster child of digital therapeutics, with multiple FDA-approved products, filed for Chapter 11 bankruptcy protection, leaving investors wondering what the future holds. Is this a bellwether for future challenges facing the industry, or an opportunity to rethink how digital-native products can be distributed and reimbursed? Panelists will examine whether FDA approval should be encouraged for products in the digital space and if there are viable reimbursement models for these solutions. Finally, panelists will discuss the potential value of evidence-based digital health and the advantages digital-native products may have over their conventional counterparts.  

Tina Reed
Senior Health Care Reporter, Axios
Robert DeLuca
President, Orexo Pharmaceuticals
Arun Gupta
CEO, Big Health
Julia Hu
CEO and Co-Founder, Lark Health
Matthew Stoudt
CEO, AppliedVR, Inc.
Troy Tazbaz
Director, Digital Health Center of Excellence, US Food and Drug Administration